Advanced Search

Study Preview



Study Title and Description

Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.
Author Budde K., Lehner F., Sommerer C., Arns W., Reinke P., Eisenberger U., Wüthrich RP., Scheidl S., May C., Paulus EM., Mühlfeld A., Wolters HH., Pressmar K., Stahl R., Witzke O.
Country Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany. klemens.budde@charite.de
Year 2012
Numbers Pubmed ID: 22642473
2252 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.